Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 21

Results For "Varian"

348 News Found

MIBCON NDC offers CO2 Optimisation module
Sustainability | March 04, 2022

MIBCON NDC offers CO2 Optimisation module

The CO2 Optimization module is one of the four modules (Product Costing, BoM Management, CO2 Optimization, Supplier Strategy) within the entire NDC Simulation Suite


WHO includes molnupiravir in its Covid-19 treatment guidelines
Biotech | March 03, 2022

WHO includes molnupiravir in its Covid-19 treatment guidelines

This ninth update of WHO’s guideline on therapeutics includes a recommendation that casirivimab-imdevimab not be used for patients infected with the Omicron variant


Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology
Biotech | March 03, 2022

Avenge Bio announces peer-reviewed publication on preclinical proof of concept for LOCOcyte platform technology

Ovarian cancer is one of the most difficult cancers to treat. It is typically not detected until later stages, and about 70 percent of patients will have recurrence after an initial treatment, which is often fatal


CryptoRelief partners with IIT Madras to establish wastewater-based research centre
Public Health | March 02, 2022

CryptoRelief partners with IIT Madras to establish wastewater-based research centre

Scientists worldwide have started employing wastewater analysis as an efficient and cost-effective approach for assessing the dynamics of the virus in a population. Several scientific methods are being developed to rapidly decode the message carried by sewage


Prenetics Partners and ACON Bio launch Covid-19 antigen kits
Medical Device | February 27, 2022

Prenetics Partners and ACON Bio launch Covid-19 antigen kits

Flowflex antigen test detects Covid-19, including the Omicron variant, in just 15 minutes with 98.8% accuracy


UK Vaccine Network funding for ConserV pan-coronavirus project
News | February 25, 2022

UK Vaccine Network funding for ConserV pan-coronavirus project

UNICOR-v has the potential to protect against future epidemics caused by a coronavirus jumping from animals to humans, but also against new variants emerging from SARS-Cov-2


Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine
News | February 24, 2022

Sanofi and GSK to seek regulatory authorization for Covid-19 vaccine

100% efficacy against severe Covid-19 disease and hospitalizations


CanSinoBIO's Convidecia approved as heterologous booster in China
News | February 21, 2022

CanSinoBIO's Convidecia approved as heterologous booster in China

Heterologous booster vaccination refers to the use of vaccine boosters from different technology platforms from the prime vaccines, which could improve the overall immune response and enhance protection against other variants


Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus
News | February 21, 2022

Panacea Biotech partners with GOI to develop protective vaccine against betacoronavirus

CEPI is accelerating its programme to develop broadly protective coronavirus vaccines—a core part of US $ 3.5 billion pandemic preparedness plan


Health Canada authorizes Novavax Covid-19 vaccine
News | February 18, 2022

Health Canada authorizes Novavax Covid-19 vaccine

Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Canada